ARCH Venture Partners
Chicago, IL, USA · Growth → Series C+
Their stated focus (public profile)
ARCH Venture Partners backs disruptive science companies founded on revolutionary technologies, with a focus on preventing, detecting, and curing disease. The firm takes a long-term, contrarian approach, investing from very early formation stages through large growth rounds, partnering with great scientists and building transformational companies. ARCH is flexible in check size, ranging from $50K to hundreds of millions per company.
Stages: Growth → Series C+
Sectors: Life sciences, Healthtech
Check size: $50K to as much as hundreds of millions of dollars, per company
On file: 15 partners on record · 7 companies on record
Website: archventure.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.